BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33438994)

  • 21. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.
    Zhang Y; Wang J; Bai X; Jiang T; Zhang Q; Wang S
    Mol Pharm; 2012 Mar; 9(3):505-13. PubMed ID: 22217205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems.
    Chen X; Liu Y; Lin A; Huang N; Long L; Gang Y; Liu J
    Biomater Sci; 2018 Jun; 6(7):1923-1935. PubMed ID: 29850668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted Delivery of Peptide Nucleic Acid by Biomimetic Nanoparticles Based on Extracellular Vesicle-coated Mesoporous Silica Nanoparticles.
    Chen W; Lai Q; Zhang Y; Mo L; Liu Z
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38251696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation.
    Singh AK; Singh SS; Rathore AS; Singh SP; Mishra G; Awasthi R; Mishra SK; Gautam V; Singh SK
    ACS Biomater Sci Eng; 2021 Aug; 7(8):3737-3753. PubMed ID: 34297529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
    Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs.
    Feng Y; Li NX; Yin HL; Chen TY; Yang Q; Wu M
    Mol Pharm; 2019 Jan; 16(1):422-436. PubMed ID: 30525641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Charge-Reversal APTES-Modified Mesoporous Silica Nanoparticles with High Drug Loading and Release Controllability.
    Wang Y; Sun Y; Wang J; Yang Y; Li Y; Yuan Y; Liu C
    ACS Appl Mater Interfaces; 2016 Jul; 8(27):17166-75. PubMed ID: 27314423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro Dissolution, Cellular Membrane Permeability, and Anti-Inflammatory Response of Resveratrol-Encapsulated Mesoporous Silica Nanoparticles.
    Juère E; Florek J; Bouchoucha M; Jambhrunkar S; Wong KY; Popat A; Kleitz F
    Mol Pharm; 2017 Dec; 14(12):4431-4441. PubMed ID: 29094948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
    Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
    Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH responsive cylindrical MSN for oral delivery of insulin-design, fabrication and evaluation.
    Guha A; Biswas N; Bhattacharjee K; Sahoo N; Kuotsu K
    Drug Deliv; 2016 Nov; 23(9):3552-3561. PubMed ID: 27540687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facile Synthesis of Chitosan Capped Mesoporous Silica Nanoparticles: A pH Responsive Smart Delivery Platform for Raloxifene Hydrochloride.
    Shah PV; Rajput SJ
    AAPS PharmSciTech; 2018 Apr; 19(3):1344-1357. PubMed ID: 29340980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gated Mesoporous Silica Nanocarriers for a "Two-Step" Targeted System to Colonic Tissue.
    González-Alvarez M; Coll C; Gonzalez-Alvarez I; Giménez C; Aznar E; Martínez-Bisbal MC; Lozoya-Agulló I; Bermejo M; Martínez-Máñez R; Sancenón F
    Mol Pharm; 2017 Dec; 14(12):4442-4453. PubMed ID: 29064714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
    Thiyagarajan V; Lin SX; Lee CH; Weng CF
    Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zwitterionic carbon dot-encapsulating pH-responsive mesoporous silica nanoparticles for NIR light-triggered photothermal therapy through pH-controllable release.
    Ryplida B; Lee G; In I; Park SY
    Biomater Sci; 2019 May; 7(6):2600-2610. PubMed ID: 30984942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Study on Photodynamic Activation of Ortho-Toluidine Blue and Methylene Blue Loaded Mesoporous Silica Nanoparticles Against Resistant Microorganisms.
    Amin A; Kaduskar DV
    Recent Pat Drug Deliv Formul; 2018; 12(3):154-161. PubMed ID: 29952275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery.
    Chen C; Sun W; Wang X; Wang Y; Wang P
    Int J Biol Macromol; 2018 May; 111():1106-1115. PubMed ID: 29357289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous Single-Particle Tracking and Dynamic pH Sensing Reveal Lysosome-Targetable Mesoporous Silica Nanoparticle Pathways.
    Zhang RL; Pratiwi FW; Chen BC; Chen P; Wu SH; Mou CY
    ACS Appl Mater Interfaces; 2020 Sep; 12(38):42472-42484. PubMed ID: 32657564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery.
    Moreira AF; Gaspar VM; Costa EC; de Melo-Diogo D; Machado P; Paquete CM; Correia IJ
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1012-25. PubMed ID: 25229810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles.
    Desai D; Prabhakar N; Mamaeva V; Karaman DŞ; Lähdeniemi IA; Sahlgren C; Rosenholm JM; Toivola DM
    Int J Nanomedicine; 2016; 11():299-313. PubMed ID: 26855569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.